🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to investigate the safety and efficacy of Rotigotine add-on t...
Status
Completed
Location
402
Start Date
2012-10
Trial ID
NCT01723904
Treatments Being Tested
The objective is to assess the effect of Neupro® on the severity of Restles...
Status
Completed
Location
12
Start Date
2011-07
Trial ID
NCT01386944
This study was intended to demonstrate bioequivalence of the Amarin's Rotig...
Status
Completed
Location
Cliantha Research Ltd.
Start Date
2025-12-04
Trial ID
NCT07769359
Treatments Being Tested
The objective of this trial is to investigate the PK (Pharmacokinetic) of r...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT01964573
Treatments Being Tested
This trial is being conducted to assess the effects of Rotigotine over Plac...
Status
Completed
Location
4320
Start Date
2013-02
Trial ID
NCT01782222
Treatments Being Tested
The purpose of this study is to show Rotigotine dose response at four doses...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00522379
Treatments Being Tested
Parkinson's disease (PD) is a neurodegenerative disorder that is characteri...
Status
Terminated
Location
Sleep Medicine Centre Kempenhaeghe
Start Date
2012-03
Trial ID
NCT01554306
The efficacy and safety of rotigotine in the treatment of patients with ear...
Status
Completed
Location
Peking University Third Hospital
Start Date
2018-08-01
Trial ID
NCT04455555
Treatments Being Tested
The primary objective of this study is to investigate efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00666965
Treatments Being Tested
To study the profile of Neupro patch administrated at 2 mg, 4 mg, 6 mg and ...
Status
Completed
Location
CNS Network
Start Date
2016-05
Trial ID
NCT02728947
Treatments Being Tested